Canntab Therapeutics Limited
PILL
Rank in Stocks
#40499
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Share Price
$0.0036163
Last synced: 2023-10-30
Market Cap
$118.21K
Change (1 day)
0.39%
Change (1 year)
3,516.30%
Country
CA
Trade Canntab Therapeutics Limited (PILL)
Category
Healthcare
Market Capitalization of Canntab Therapeutics Limited(PILL)
Market Cap: $118.21K
As of October 2026 Canntab Therapeutics Limited has a market cap of $118.21K. This makes Canntab Therapeutics Limited the world's 40499th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Canntab Therapeutics Limited from 2017 to 2026
PILL compared with Top 5 Most Popular stocks
